[Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983]. 1984

R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot

Susceptibility of 16 056 strains isolated in 1982 and 1983 to fosfomycin (FOS) was tested with Mueller-Hinton medium and discs 50 micrograms FOS + 25 micrograms glucose-6-phosphate (G6P) (cutoff diameter 14 mm). For 3 411 strains, inhibition zone diameters were recorded. Almost all E. coli, Citrobacter, Salmonella and S. aureus were susceptible to FOS as well as 70% of Serratia, E. cloacae, P. mirabilis and 50% of Klebsiella and Enterobacter sp. Only 27% of P. aeruginosa, 20% of indole positive Proteus and 8% of Acinetobacter were sensitive to FOS. E. coli, Citrobacter and S. aureus seem to exhibit the highest susceptibilities to FOS. Sensitivity rates of E. cloacae, Serratia, P. aeruginosa, and especially Klebsiella seemed slightly underestimated by the disk diffusion method, but differentiation between susceptible and resistant strains was facilitated by rating as susceptible those strains with inhibition zone diameters between 12 and 14 mm. This method also seemed to underrate the sensitivity of susceptible Enterobacteriaceae, probably because of inadequate G6P concentrations at this point of the disk.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D005578 Fosfomycin An antibiotic produced by Streptomyces fradiae. Phosphonomycin,Fosfomycin Trometamol Salt,Fosfomycin Tromethamine,Monuril,Phosphomycin,Tromethamine, Fosfomycin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000150 Acinetobacter A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity. Herellea,Mima
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.

Related Publications

R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1990, Annales de medecine interne,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1984, Annales de medecine interne,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
May 1984, Pathologie-biologie,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1984, Revue neurologique,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1991, Revue neurologique,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1986, Mikrobiologicheskii zhurnal,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1977, Giornale italiano di chemioterapia,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1993, Revue neurologique,
R Bismuth, and V Jarlier, and M H Nicolas, and J Nguyen, and C Truffot
January 1977, Chemotherapy,
Copied contents to your clipboard!